Viewing Study NCT00920595


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-01-01 @ 12:45 PM
Study NCT ID: NCT00920595
Status: COMPLETED
Last Update Posted: 2012-08-16
First Post: 2009-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors
Sponsor: Cephalon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View